EGFR and colorectal carcinoma: For example, antibodies targeting vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) have been developed and widely used to treat CRC.[4, 5, 6] Further exploration of the genes and signaling pathways involved in colorectal cancer would help to identify new prognostic and therapeutic targets.